Acute Management of Bleeding Oesophageal Varices

Overview

Journal Drugs

Specialty Pharmacology

Date 1992 Jan 1

PMID 1385067

Authors

A K Burroughs

Affiliations

Soon will be listed here.

Abstract

The goals of therapy in acute variceal bleeding are to arrest haemorrhage and to prevent deterioration of liver function and complications related to bleeding. The measures used to stop acute bleeding should, ideally, also prevent the very early rebleeding that is frequently seen with bleeding varices. Variceal bleeding should be managed by a gastrointestinal bleeding team with intensive nursing care. Diagnostic endoscopy is mandatory once initial resuscitation has been achieved, and allows immediate injection sclerotherapy of varices. Drug therapy can be used as the first treatment in patients admitted with variceal bleeding since it can be given immediately. Of the available drugs, somatostatin has the least side effects and is as effective as vasopressin, terlipressin and the combination of vasopressin and an organic nitrate vasodilator. The role of drugs needs to be studied in combination with sclerotherapy. Sclerotherapy remains the mainstay of management as it achieves the twin goals of stopping active bleeding and preventing early rebleeding. Injection of tissue adhesive and endoscopic ligation or 'banding' are new endoscopic techniques that have shown promise in preliminary trials and are currently being assessed more widely. Balloon tamponade is a temporary measure used to prevent exsanguination. Surgery should be reserved for those patients in whom sclerotherapy is unsuccessful or cannot be carried out. Oesophageal staple transection is the most used operation. The new interventional radiological technique of transjugular intrahepatic portosystemic shunting will probably replace surgery in the future, but its role in acute variceal bleeding has yet to be fully defined.

References

de Dombal F, Clarke J, Clamp S, Malizia G, Kotwal M, Morgan A . Prognostic factors in upper G.I. bleeding. Endoscopy. 1986; 18 Suppl 2:6-10. DOI: 10.1055/s-2007-1018418. View

Perarnau J, Noeldge G, Rossle M . [Intrahepatic portacaval anastomosis by the transjugular approach. Use of the Palmaz endoprosthesis]. Presse Med. 1991; 20(36):1770-2. View

Stiegmann G, Goff J, Sun J, Wilborn S . Endoscopic elastic band ligation for active variceal hemorrhage. Am Surg. 1989; 55(2):124-8. View

Fogel M, Knauer C, Andres L, Mahal A, Stein D, Kemeny M . Continuous intravenous vasopressin in active upper gastrointestinal bleeding. Ann Intern Med. 1982; 96(5):565-9. DOI: 10.7326/0003-4819-96-5-565. View

Richter G, Noeldge G, Palmaz J, Roessle M . The transjugular intrahepatic portosystemic stent-shunt (TIPSS): results of a pilot study. Cardiovasc Intervent Radiol. 1990; 13(3):200-7. DOI: 10.1007/BF02575474. View

Burroughs A . Somatostatin and octreotide for variceal bleeding. J Hepatol. 1991; 13(1):1-4. DOI: 10.1016/0168-8278(91)90854-5. View

Garden O, Motyl H, Gilmour W, Utley R, Carter D . Prediction of outcome following acute variceal haemorrhage. Br J Surg. 1985; 72(2):91-5. DOI: 10.1002/bjs.1800720205. View

MERIGAN Jr T, PLOTKIN G, Davidson C . Effect of intravenously administered posterior pituitary extract on hemorrhage from bleeding esophageal varices. A controlled evaluation. N Engl J Med. 1962; 266:134-5. DOI: 10.1056/NEJM196201182660307. View

Burroughs A, McCormick P, Hughes M, Sprengers D, DHeygere F, McIntyre N . Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Emergency control and prevention of early variceal rebleeding. Gastroenterology. 1990; 99(5):1388-95. DOI: 10.1016/0016-5085(90)91166-4. View

10.

MacMathuna P . Mechanisms and consequences of portal hypertension. Drugs. 1992; 44 Suppl 2:1-13; discussion 70-2. DOI: 10.2165/00003495-199200442-00003. View

11.

Soehendra N, Grimm H, Maydeo A, Nam V, Eckmann B, Bruckner M . Endoscopic sclerotherapy--personal experience. Hepatogastroenterology. 1991; 38(3):220-3. View

12.

LHERMINE C, Chastanet P, Delemazure O, Bonniere P, Durieu J, Paris J . Percutaneous transhepatic embolization of gastroesophageal varices: results in 400 patients. AJR Am J Roentgenol. 1989; 152(4):755-60. DOI: 10.2214/ajr.152.4.755. View

13.

Jenkins S . Somatostatin in acute bleeding oesophageal varices. Clinical evidence. Drugs. 1992; 44 Suppl 2:36-55; discussion 70-2. DOI: 10.2165/00003495-199200442-00006. View

14.

Burroughs A, Hamilton G, Phillips A, Mezzanotte G, McIntyre N, Hobbs K . A comparison of sclerotherapy with staple transection of the esophagus for the emergency control of bleeding from esophageal varices. N Engl J Med. 1989; 321(13):857-62. DOI: 10.1056/NEJM198909283211303. View

15.

Cello J, Grendell J, Crass R, Weber T, Trunkey D . Endoscopic sclerotherapy versus portacaval shunt in patients with severe cirrhosis and acute variceal hemorrhage. Long-term follow-up. N Engl J Med. 1987; 316(1):11-5. DOI: 10.1056/NEJM198701013160103. View

16.

Larson A, Cohen H, Zweiban B, Chapman D, Gourdji M, Korula J . Acute esophageal variceal sclerotherapy. Results of a prospective randomized controlled trial. JAMA. 1986; 255(4):497-500. View

17.

McCormick P, Kaye G, Greenslade L, Cardin F, Hobbs K, McIntyre N . Esophageal staple transection as a salvage procedure after failure of acute injection sclerotherapy. Hepatology. 1992; 15(3):403-6. DOI: 10.1002/hep.1840150308. View

18.

Vinel J, Cassigneul J, Levade M, Voigt J, Pascal J . Assessment of short-term prognosis after variceal bleeding in patients with alcoholic cirrhosis by early measurement of portohepatic gradient. Hepatology. 1986; 6(1):116-7. DOI: 10.1002/hep.1840060122. View

19.

Freeman J, Cobden I, Record C . Placebo-controlled trial of terlipressin (glypressin) in the management of acute variceal bleeding. J Clin Gastroenterol. 1989; 11(1):58-60. DOI: 10.1097/00004836-198902000-00014. View

20.

McCormick P, Burroughs A, McIntyre N . How to insert a Sengstaken-Blakemore tube. Br J Hosp Med. 1990; 43(4):274-7. View